Report Highlights
The global market for protein analysis should grow from $11.6 billion in 2018 to $19.0 billion by 2023 at a compound annual growth rate (CAGR) of 10.4% from 2018 through 2023.
Report Includes
- 56 data tables and 37 additional tables
- An overview of the global market for protein analysis and oncoproteomics within the biotechnology industry
- Analyses of global market trends with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Coverage of the current market for drug discovery, clinical diagnostic and research into personalized medicine and so forth
- Discussion of factors such as global rise in infectious and noninfectious diseases, growing population, technological advancements and innovation, which create considerable demand within the protein analysis market
- Relevant patents analysis, clinical trials, innovations and opportunities
- Evaluation of key trends, present and future market strategies, technological advancements, and regulatory updates that have a major say in the protein analysis market
- Company profiles of the leading industry players, including Bio-Rad Laboratories Inc., Danaher Corp., GE Healthcare, GlaxoSmithKline PLC, GD Biosciences and Pfizer
Report Scope
The protein analysis market has significant potential bolstered by the rising demand from drug discovery and personalized medicine. The capabilities and possibilities of protein analysis market growth increase with growing new technologies and technological advancement in the market. Emerging economies such as China, Japan and South Korea are considered to be lucrative regions that are creating ample opportunities and scope for the protein analysis market. This market is expected to obtain investments and funding from government and private ventures, research institutes and universities to explore its potential. Growing clinical trials, drug discovery and clinical diagnostic and research through the protein analysis market will further boost this market in the near future. Sedentary lifestyles, unhealthy eating habits and upsurge in infectious viral and bacterial diseases are also creating opportunities for the protein analysis market. The global rise in infectious and noninfectious diseases, growing population, technological advancements and innovation are some other factors creating considerable demand within the protein analysis market.
The scope of this study covers the current market for drug discovery, clinical diagnostic and research into personalized medicine and so forth. The report also includes regulatory aspects, current and developing technologies, market projections and market share. Patents, clinical trials, innovations and opportunities, as well as the latest trends are also analyzed and discussed. The report intends to explain the key trends of protein analysis technologies. It also discusses the market determinants that act as motivating and restraining factors and provides insights to stakeholders and potential entrants. The report will be a key decision-making tool for government organizations, researchers, private players, angel investors, potential entrants and so forth.
Analyst Credentials
ANUJ PATHAK has written and researched the global medical device market, surgical instruments and biotechnology market. Skilled in information technology and computer management, he has an undergraduate business degree and an MBA degree.
Related Reports
Glycobiology: Global Markets for Diagnostics and Therapeutics
The global glycobiology market should reach $5.3 billion by 2027 from $3.2 billion in 2022 at a compound annual growth rate (CAGR) of 11.1% for the forecast period of 2022 to 2027.
Plant-Based Protein: Global Markets
The global market for plant-based proteins is estimated to increase from $11.8 billion in 2022 to $17.8 billion by 2027, at a compound annual growth rate (CAGR) of 8.5% from 2022 through 2027.
Protein Sequencing: Global Market
The global market for protein sequencing should grow from $1.3 billion in 2021 to $1.6 billion by 2026 with a compound annual growth rate (CAGR) of 4.6% for the period of 2021-2026.
Drug Discovery Technologies
The global market for drug discovery technologies should grow from $69.8 billion in 2020 to $110.4 billion by 2025 with a compound annual growth rate (CAGR) of 9.6% for the period of 2020-2025.
Recent Reports
Companion Diagnostics: Technologies and Markets
The global market for companion diagnostics is estimated to increase from $7.6 billion in 2023 to reach $15.4 billion by 2028, at a compound annual growth rate (CAGR) of 15.2% from 2023 through 2028.
Exosome Diagnostics, Therapeutics and Research Tools: Global Markets
The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.
Peptide Synthesis: Global Markets
The global market for peptide synthesis is expected to grow from $90.1 billion in 2023 and projected to reach $157.5 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.8% during the forecast period of 2023 to 2028.
Oligonucleotides: Global Markets
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Global Market for Cell and Gene Therapy
The global market for cell and gene therapy is expected to grow from $7.2 billion in 2023 and projected to reach $23.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 26.4% during the forecast period of 2023 to 2028.
Top Trending Reports
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.
ESG Trends in Chemical Industry
This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the chemical industry.
Digital Pathology: Technologies and Global Markets
The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.
Smartphone-Based Patient Monitoring: Global Market
The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.
Seawater and Brackish Water Desalination
The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More